{"version":"1.0","provider_name":"Tris Pharma","provider_url":"https:\/\/www.trispharma.com","title":"Tris announces US District Court Upholds Validity of Quillivant XR\u00ae Patents; Rules Teva Infringes Tris Patents - Tris Pharma","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"usnZM1ZKUD\"><a href=\"https:\/\/www.trispharma.com\/tris-announces-us-district-court-upholds-validity-of-quillivant-xr-patents-rules-teva-infringes-tris-patents\/\">Tris announces US District Court Upholds Validity of Quillivant XR\u00ae Patents;  Rules Teva Infringes Tris Patents<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.trispharma.com\/tris-announces-us-district-court-upholds-validity-of-quillivant-xr-patents-rules-teva-infringes-tris-patents\/embed\/#?secret=usnZM1ZKUD\" width=\"600\" height=\"338\" title=\"&#8220;Tris announces US District Court Upholds Validity of Quillivant XR\u00ae Patents;  Rules Teva Infringes Tris Patents&#8221; &#8212; Tris Pharma\" data-secret=\"usnZM1ZKUD\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"MONMOUTH JUNCTION, December 1, 2020 \/ PRNewswire\/ \u2013 Tris Pharma, Inc. (\u201cTris\u201d), a specialty pharmaceutical company with a robust portfolio of approved products for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, announced the decision by the US District Court for the District of Delaware to uphold the validity of various patents [&hellip;]"}